ZA978799B - Mycosis vaccine. - Google Patents

Mycosis vaccine.

Info

Publication number
ZA978799B
ZA978799B ZA9708799A ZA978799A ZA978799B ZA 978799 B ZA978799 B ZA 978799B ZA 9708799 A ZA9708799 A ZA 9708799A ZA 978799 A ZA978799 A ZA 978799A ZA 978799 B ZA978799 B ZA 978799B
Authority
ZA
South Africa
Prior art keywords
mycosis
vaccine
mycosis vaccine
Prior art date
Application number
ZA9708799A
Other languages
English (en)
Inventor
Igor Dimitrievich Poliakov
G Ludmilla Ivanova
Original Assignee
Boehringer Ingelheim Int
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Int
Publication of ZA978799B publication Critical patent/ZA978799B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/165—Yeast isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/72—Candida
    • C12R2001/725—Candida albicans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9708799A 1996-10-04 1997-10-01 Mycosis vaccine. ZA978799B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96115954A EP0834322A3 (fr) 1996-10-04 1996-10-04 Vaccins pour traiter des mycoses

Publications (1)

Publication Number Publication Date
ZA978799B true ZA978799B (en) 1998-04-06

Family

ID=8223269

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708799A ZA978799B (en) 1996-10-04 1997-10-01 Mycosis vaccine.

Country Status (17)

Country Link
US (1) US6290950B1 (fr)
EP (2) EP0834322A3 (fr)
JP (1) JP4698771B2 (fr)
AR (1) AR008491A1 (fr)
AT (1) ATE347372T1 (fr)
AU (1) AU740389B2 (fr)
CA (1) CA2268138C (fr)
CO (1) CO4650185A1 (fr)
DE (1) DE69737067T2 (fr)
DK (1) DK0956042T3 (fr)
ES (1) ES2279546T3 (fr)
HR (1) HRP970528A2 (fr)
PE (1) PE2399A1 (fr)
PT (1) PT956042E (fr)
RU (1) RU2219945C2 (fr)
WO (1) WO1998015284A2 (fr)
ZA (1) ZA978799B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
US6720576B1 (en) * 1992-09-11 2004-04-13 Semiconductor Energy Laboratory Co., Ltd. Plasma processing method and photoelectric conversion device
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
WO2001015725A1 (fr) * 1998-09-24 2001-03-08 Alpharma As Vaccin permettant de proteger un animal vertebre contre une mycose cutanee
EP1303300B1 (fr) * 2000-06-19 2010-08-11 Hunter Immunology Limited Compositions et procedes de traitement de la candidiase
US20040009937A1 (en) * 2002-01-31 2004-01-15 Wei Chen Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
US20050075298A1 (en) * 2002-01-31 2005-04-07 Wei Chen Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
US20040043003A1 (en) * 2002-01-31 2004-03-04 Wei Chen Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
RU2281110C1 (ru) * 2005-02-10 2006-08-10 Владислав Николаевич Ласкавый Лекарственное средство против кандидоза человека для инъекций
EP2063905B1 (fr) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
US20080220023A1 (en) * 2007-03-08 2008-09-11 Stevens David A Antifungal vaccines with saccharomyces cerevisiae
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
ES2878071T3 (es) 2016-03-15 2021-11-18 Igor Polyakov Nuevos productos inmunobiológicos
MX2018010710A (es) 2016-03-15 2019-01-14 Polyakov Igor Composiciones para el tratamiento y prevención de enfermedades podales y de las pezuñas.
WO2021001540A1 (fr) 2019-07-04 2021-01-07 Proxi Biotech Aps Détoxification de protéines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU835446A1 (ru) * 1978-06-07 1981-06-07 Всесоюзный Ордена Ленина Институтэкспериментальной Ветеринариивсесоюзной Ордена Ленина Академиисельскохозяйственных Науким. B.И.Ленина Вакцина дл специфической профилактики и лЕчЕНи ТРиХОфиТии пушНыХ зВЕРЕй иКРОлиКОВ-MEHTABAK,СпОСОб изгОТОВлЕНи ВАКциНы и СпОСОб EE иСпОльзОВАНи
AU547928B2 (en) * 1981-11-03 1985-11-14 Sutka, K. Antigenic preparation from candida guilliermondii
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
CA2011896C (fr) 1989-04-21 2001-05-08 Mark Werner Vaccin contre la teigne
DE4007927A1 (de) * 1990-03-13 1991-09-19 Bayer Ag Pathogenese-faktoren von dermatophyten
US5277904A (en) * 1990-10-26 1994-01-11 Pier Allan C Broad spectrum dermatophyte vaccine
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
GB2304347A (en) * 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
WO1998009990A1 (fr) * 1996-09-04 1998-03-12 Takara Shuzo Co., Ltd. Antigenes fongiques et processus de fabrication

Also Published As

Publication number Publication date
EP0956042A2 (fr) 1999-11-17
PT956042E (pt) 2007-04-30
WO1998015284A3 (fr) 1999-09-23
US6290950B1 (en) 2001-09-18
PE2399A1 (es) 1999-02-10
EP0956042B1 (fr) 2006-12-06
CA2268138C (fr) 2009-01-06
CO4650185A1 (es) 1998-09-03
WO1998015284A2 (fr) 1998-04-16
AU740389B2 (en) 2001-11-01
JP4698771B2 (ja) 2011-06-08
ATE347372T1 (de) 2006-12-15
AR008491A1 (es) 2000-01-19
RU2219945C2 (ru) 2003-12-27
CA2268138A1 (fr) 1998-04-16
EP0834322A2 (fr) 1998-04-08
DE69737067D1 (de) 2007-01-18
DE69737067T2 (de) 2007-07-05
JP2001503975A (ja) 2001-03-27
EP0834322A3 (fr) 1998-04-22
DK0956042T3 (da) 2007-04-10
HRP970528A2 (en) 1998-08-31
AU4460497A (en) 1998-05-05
ES2279546T3 (es) 2007-08-16

Similar Documents

Publication Publication Date Title
ZA9811848B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
CY2410B1 (en) Novel device.
ZA977206B (en) Arylalkanoylpyridazines.
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA975034B (en) Airship.
EP0669276A3 (fr) Système d'élévation.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA978799B (en) Mycosis vaccine.
ZA966773B (en) Sulfonyl-or sulfinyl-benzoylguanidin derivate.
ZA987662B (en) Neospora Vaccine.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA972687B (en) Finger-protective device.
ZA97928B (en) Novel heteroaryl-oxazolidinones.
ZA974052B (en) New benzothiazolinones.
ZA976022B (en) Cycloalkano-pyridines.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA9710318B (en) Safe re-locker.
ZA97310B (en) Pharmaceuticals.
CY2322B1 (en) Benzoaeguequinoline derivatives.